These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 16368722

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hormonal contraceptive patch].
    Lidegaard O.
    Ugeskr Laeger; 2004 Oct 04; 166(41):3591. PubMed ID: 15515462
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise.
    Abrams LS, Skee DM, Natarajan J, Wong FA, Leese PT, Creasy GW, Shangold MM.
    J Clin Pharmacol; 2001 Dec 04; 41(12):1301-9. PubMed ID: 11762557
    [Abstract] [Full Text] [Related]

  • 5. How should we advise patients about the contraceptive patch, given the FDA warning?
    Thacker HL, Falcone T, Atreja A, Jain A, Harris CM.
    Cleve Clin J Med; 2006 Jan 04; 73(1):45-7. PubMed ID: 16444915
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches.
    Abrams LS, Skee DM, Wong FA, Anderson NJ, Leese PT.
    J Clin Pharmacol; 2001 Nov 04; 41(11):1232-7. PubMed ID: 11697756
    [Abstract] [Full Text] [Related]

  • 7. Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
    Bifano M, Sevinsky H, Hwang C, Kandoussi H, Jiang H, Grasela D, Bertz R.
    Antivir Ther; 2014 Nov 04; 19(5):511-9. PubMed ID: 24343001
    [Abstract] [Full Text] [Related]

  • 8. Transdermal contraception.
    Creasy GW, Abrams LS, Fisher AC.
    Semin Reprod Med; 2001 Dec 04; 19(4):373-80. PubMed ID: 11727179
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
    Zieman M.
    Fertil Steril; 2002 Feb 04; 77(2 Suppl 2):S1-2. PubMed ID: 11849629
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The transdermal contraceptive patch: a new approach to hormonal contraception.
    Burkman RT.
    Int J Fertil Womens Med; 2002 Feb 04; 47(2):69-76. PubMed ID: 11991433
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A transdermal form of combined hormonal contraceptives (EVRA)].
    Fanta M.
    Ceska Gynekol; 2003 Oct 04; 68(5):341-5. PubMed ID: 14692356
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.